ticlopidine has been researched along with Adverse Effects, Long Term in 3 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godschalk, TC | 1 |
| Gimbel, ME | 1 |
| Nolet, WW | 1 |
| van Kessel, DJ | 1 |
| Amoroso, G | 1 |
| Dewilde, WJ | 1 |
| Wykrzykowska, JJ | 1 |
| Janssen, PW | 1 |
| Bergmeijer, TO | 1 |
| Kelder, JC | 1 |
| Heestermans, T | 1 |
| Ten Berg, JM | 1 |
| Zhang, Y | 1 |
| Zhao, Y | 1 |
| Pang, M | 1 |
| Wu, Y | 1 |
| Zhuang, K | 1 |
| Zhang, H | 1 |
| Bhat, A | 1 |
| Goodman, SG | 1 |
| Nicolau, JC | 1 |
| Requena, G | 1 |
| Maguire, A | 1 |
| Blankenberg, S | 1 |
| Chen, JY | 1 |
| Granger, CB | 1 |
| Grieve, R | 1 |
| Pocock, SJ | 1 |
| Simon, T | 1 |
| Yasuda, S | 1 |
| Vega, AM | 1 |
| Brieger, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients[NCT01866904] | 9,284 participants (Actual) | Observational | 2013-06-19 | Terminated (stopped due to Study was terminated in order to secure the data quality of the study in terms of follow-up rates and data completeness.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ticlopidine and Adverse Effects, Long Term
| Article | Year |
|---|---|
High-dose clopidogrel versus ticagrelor for treatment of acute coronary syndromes after percutaneous coronary intervention in CYP2C19 intermediate or poor metabolizers: a prospective, randomized, open-label, single-centre trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; China; Clopidogrel; Cytochrome P-450 CYP2C19; Dose-Respons | 2016 |
2 other studies available for ticlopidine and Adverse Effects, Long Term
| Article | Year |
|---|---|
A clinical risk score to identify patients at high risk of very late stent thrombosis.
Topics: Aspirin; Case-Control Studies; Female; Hemorrhage; Humans; Long Term Adverse Effects; Male; Middle A | 2018 |
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Femal | 2017 |